N ormal pregnancy profoundly alters fluid balance and arterial pressure (AP) regulation. Blood volume and cardiac output increase, but AP falls because of decreases in systemic vascular resistance. 1 To partially counteract primary vasodilation and hypotension, pregnancy increases sympathetic nerve activity (SNA) to several organs, including the heart, 2-4 adrenal, 5 kidney, 6 and skeletal muscle. [7][8][9] In contrast, in women with preeclampsia, blood volume expansion is blunted and hypertension is produced, 10 with further increases in SNA. 7,8, 11 Preeclampsia is a complication of considerable medical importance; it occurs in 6% to 10% of pregnant women and ranks among the top causes of maternal death. 10 Therefore, it is imperative to understand the mechanisms that contribute, including the elevations in SNA. However, before we can understand preeclampsia, we first need to identify the mechanisms by which normal pregnancy increases SNA because preeclampsia may exaggerate these same mechanisms. Remarkably, little information is currently available.
N ormal pregnancy profoundly alters fluid balance and arterial pressure (AP) regulation. Blood volume and cardiac output increase, but AP falls because of decreases in systemic vascular resistance. 1 To partially counteract primary vasodilation and hypotension, pregnancy increases sympathetic nerve activity (SNA) to several organs, including the heart, 2-4 adrenal, 5 kidney, 6 and skeletal muscle. [7] [8] [9] In contrast, in women with preeclampsia, blood volume expansion is blunted and hypertension is produced, 10 with further increases in SNA. 7, 8, 11 Preeclampsia is a complication of considerable medical importance; it occurs in 6% to 10% of pregnant women and ranks among the top causes of maternal death. 10 Therefore, it is imperative to understand the mechanisms that contribute, including the elevations in SNA. However, before we can understand preeclampsia, we first need to identify the mechanisms by which normal pregnancy increases SNA because preeclampsia may exaggerate these same mechanisms. Remarkably, little information is currently available.
The rostral ventrolateral medulla is a major source of basal sympathetic tone in normal individuals; yet inhibition of rostral ventrolateral medulla presympathetic neurons by gammaaminobutyric acid (GABA) is increased during pregnancy, 12 at variance with a major role. In contrast, although the paraventricular nucleus (PVN) of the hypothalamus normally contributes little to basal sympathetic tone, indirect evidence suggests that the PVN may underlie basal sympathoexcitation in pregnancy. More specifically, sympathoinhibitory influences in the PVN, including the considerable tonic GABAergic restraint 13, 14 and the expression and activity of neuronal nitric oxide synthase, 15, 16 decreases. However, whether this decreased inhibition translates into higher tonic support of basal SNA is unknown. Therefore, the first purpose of the present experiments was to test the hypothesis that the PVN is a source of elevated basal SNA drive, by determining whether PVN inhibition, via bilateral nanoinjection of muscimol, decreases lumbar SNA (LSNA) and AP more in pregnant rats than in nonpregnant anesthetized rats.
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Another tonic inhibitor of PVN presympathetic neurons is neuropeptide Y (NPY). 17 PVN NPY expression is reduced during pregnancy, at least in mice; 18 however, whether tonic NPY inhibition of SNA decreases during pregnancy, like GABA, is unknown. Therefore, we used immunohistochemistry to quantify PVN NPY expression in pregnant and nonpregnant rats and tested whether blockade of PVN type 1 NPY receptors (NPY1x) increases LSNA less in pregnant rats than in nonpregnant rats. Because inhibitory NPY inputs converge with excitatory α-melanocyte-stimulating hormone (α-MSH) inputs onto PVN presympathetic neurons, 17 we next tested whether blockade of melanocortin type 3/4 receptors (MC3/4R) decreases SNA in pregnant rats. Finally, because a major source of both NPY and α-MSH inputs into the PVN is the arcuate nucleus (ArcN), we tested whether the ArcN also contributes to increased basal SNA, by determining the effects of ArcN muscimol in pregnant and nonpregnant rats.
Methods
An expanded Methods section is available in the online-only Data Supplement.
Animals
Experiments were performed using female virgin or pregnant Sprague-Dawley rats. For pregnant animals, the presence of sperm was designated pregnancy day 0, and experiments were performed on pregnancy day 20. All procedures were conducted in accordance with the National Institutes of Health's Guide for the Health and Use of Laboratory Animals and were approved by the Institutional (Oregon Health & Science University) Animal Care and Use Committee.
Surgery
Anesthesia was induced and maintained with 2% to 5% isoflurane in 100% oxygen. The rat was then surgically prepared with a tracheal tube, femoral arterial and venous catheters, and stainless steel electrodes around the lumbar, splanchnic, or renal sympathetic nerves and for PVN or ArcN nanoinjections, as previously described. 17, 19 After surgery, isoflurane anesthesia was slowly transitioned to a continuous intravenous infusion of α-chloralose. Virgin rats received a loading dose of 50 mg kg −1 for 30 minutes followed by a maintenance dose of 25 mg kg −1 h −1 ; pregnant rats received a dose equivalent to the weight of a virgin rat at a similar age. After the α-chloralose loading dose, rats were allowed to stabilize for ≥60 minutes before experimentation.
PVN and ArcN Nanoinjections
As previously described, 20 all nanoinjections (60 nL for PVN and 30 nL for ArcN) were made bilaterally, with ≈2 minutes between injections, and each injection was conducted over ≈5 to 10 s using a pressure injection system. The following drugs and chemicals were used: muscimol (1 mmol/L), SHU9119 (blocks MC3/4R; 0.5 mmol/L in artificial cerebrospinal fluid [aCSF] with 10% dimethyl sulfoxide), BIBO 3304 (blocks NPY Y1R; 1 mmol/L), and NPY (0.1 mmol/L). In some animals, before nanoinjection of drugs, aCSF was injected into the ArcN or PVN as a vehicle control.
Immunocytochemistry
Paired pregnant and nonpregnant rats were deeply anesthetized and perfused with 4% paraformaldehyde. The brains were removed, sectioned, and processed for immunohistochemical detection of NPY as previously described. 17, 20 The sections were imaged in pairs, and staining was quantified using ImageJ.
Data Analysis
All data are presented as mean±SEM. Maximal responses (30 s) to PVN and ArcN nanoinjections were compared using 2-and 3-way repeated measures ANOVA. PVN NPY fiber densities were compared between pregnant and nonpregnant rats using a Student t test. All data are presented as mean±SEM. P values of <0.05 were considered statistically significant.
Results
Baseline Values
Pregnancy decreased AP and increased heart rate (HR) and LSNA ( Figure S1 in the online-only Data Supplement). In the limited numbers of rats tested, we also observed increased splanchnic SNA (SSNA); however, renal SNA (RSNA) was not significantly different between pregnant rats and nonpregnant rats ( Figure S1 ).
Blockade of the PVN
As shown in Figure 1 , bilateral PVN nanoinjections of muscimol significantly decreased (P<0.05) mean arterial pressure (MAP), HR, and LSNA in pregnant rats but decreased (P<0.05) only MAP and HR in nonpregnant rats; these variables began to fall immediately and reached a nadir in 7±1 minute after initiating the nanoinjections in both groups. aCSF had no effects in either group. The decreases in MAP, HR, and LSNA were greater in pregnant rats than in nonpregnant rats and also greater compared with the effects of aCSF. Collectively, these data indicate that the PVN supports elevated LSNA during pregnancy in rats.
Paraventricular Nucleus NPY
As depicted in representative PVN sections in Figure 2 , NPY immunoreactivity was lower in pregnant rats compared with nonpregnant rats, as in mice. 18 In 4 experiments, the intensity of staining in pregnant rats was 61±8% of nonpregnant rats (P<0.05). To test whether the reduced NPY expression is functionally significant, we determined the effects of acute NPY1x in nonpregnant and pregnant animals. NPY1x increased (P<0.05; maximum reached at 9.3±0.5 minutes) MAP, HR, and LSNA more in nonpregnant rats than in pregnant rats (P<0.05; Figure 3 ). Indeed, this treatment was ineffective in pregnant rats. Nevertheless, the sympathoinhibitory, bradycardic, and depressor responses (all P<0.05) to PVN NPY injections were similar between groups ( Figure 4 ).
Paraventricular Nucleus MC3/4R
We have shown that PVN NPY inputs directly inhibit presympathetic neurons also activated by α-MSH. 17 Therefore, because pregnancy reduced tonic PVN NPY inhibition of SNA, we next determined whether elevated basal SNA is mediated in part by increased MC3/4R drive of PVN neurons. As shown previously, 21, 22 PVN nanoinjection of SHU9119 had no effects in nonpregnant rats. In contrast, PVN SHU9119 significantly decreased (P<0.05) MAP, HR, and LSNA in pregnant rats, reaching a nadir in 5±1 minute. Thus, the decreases in MAP, HR, and LSNA were greater in pregnant rats than in nonpregnant rats. These data support the hypothesis that elevated LSNA is supported at least in part by PVN MC3/4R ( Figure 5 ).
Blockade of the ArcN
PVN NPY inputs originate largely from the ArcN and brain stem, 23, 24 and α-MSH inputs primarily arise from the ArcN, 25 suggesting that the ArcN contributes to SNA support during pregnancy. Therefore, we quantified the effects of acute ArcN blockade. A key feature of this protocol is that we studied not only LSNA but also RSNA and SSNA, given the diverse effects of the ArcN on reproduction, energy balance, and AP regulation, as well as the limited information on ArcN control of SNA. Although ArcN aCSF had no significant effects, ArcN muscimol injections decreased (P<0.05) MAP in both nonpregnant and pregnant rats, with the maximum response occurring after 6.1±0.4 minutes in pregnant rats and 6.5±0.4 minutes in nonpregnant rats. However, the depressor response was significantly greater in pregnant rats. ArcN muscimol also decreased (P<0.05) HR in both groups, but the nadir was delayed compared with the decreases in MAP (pregnant: 8.5±0.4 minutes; nonpregnant: 6.9±0.6 minutes), and the responses were not significantly different between groups. On the other hand, ArcN muscimol decreased (P<0.05) LSNA, SSNA, and RSNA in pregnant rats more than either ArcN muscimol injections in nonpregnant rats or aCSF injections in either group, and the falls occurred simultaneously with the decreases in MAP. Collectively, these data 
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indicate that the ArcN supports SNA and MAP during pregnancy ( Figure 6 ).
Histological Verification of Injection Sites
Figures S2 and S3 summarize the location of PVN and ArcN injection sites.
Discussion
The purpose of this study was to test whether the PVN contributes to increased basal SNA in pregnant rats and to begin to investigate PVN inputs that drive this elevated sympathetic tone. We confirm that pregnancy decreases MAP and profoundly elevates basal SNA and HR. Our major new findings are (1) acute PVN inhibition decreases MAP, HR, and LSNA more in pregnant rats than in nonpregnant rats; (2) PVN NPY expression is reduced in pregnant rats; blockade of PVN NPY1R increases MAP, HR, and LSNA in nonpregnant rats but not in pregnant rats, yet responses to PVN NPY are preserved during pregnancy; (3) blockade of PVN MC3/4R decreases MAP, HR, and LSNA more in pregnant rats than in nonpregnant rats; and (4) acute ArcN inhibition decreases MAP, LSNA, RSNA, and SSNA more in pregnant rats than in nonpregnant rats. Collectively, these data indicate that both the PVN and the ArcN contribute to pregnancy-induced increases in basal SNA, likely in part due to decreased tonic PVN NPY inhibition and also to increased tonic PVN α-MSH stimulation. Previous studies have documented increased SNA to multiple organs during pregnancy, 2-9 and we show for the first time that SSNA is also markedly elevated. Increased RSNA has been detected in 1 study 6 but not in others 26, 27 ; we also did not observe such an elevation. This inconsistency may be explained by methodological differences and also the difficulty in detecting small between-group differences in SNA because of variations in experimental preparation. In support, we found that acute ArcN inhibition produced a small fall in RSNA, as it did in LSNA and SSNA, suggesting that at least ArcN drive of RSNA is increased in pregnant rats.
A key finding was that acute PVN inhibition profoundly decreases MAP, HR, and LSNA more in pregnant rats than in nonpregnant rats, indicating that the PVN supports elevated SNA and HR during pregnancy. A major contributor to this increased SNA may be reduced tonic inhibition of PVN presympathetic neurons. In addition to the previously reported decreases in GABAergic 13, 14 and neuronal nitric oxide synthase-mediated 15 SNA suppression, our data suggest that tonic PVN NPY inhibition of SNA is also lessened. First, similar to the mouse, 18 we found that PVN NPY expression is decreased in pregnant rats. Second, PVN NPY-induced sympathoinhibition was preserved, but the normal sympathoexcitatory response to PVN NPY Y1R blockade was abolished in pregnant rats. The failure of NPY1x to increase SNA in pregnant rats cannot be because the elevated basal SNA has reached a maximal level because baroreceptor unloading 12, 14 and PVN nanoinjection of the GABA A antagonist, bicuculline, 13, 14 can both increase SNA further in pregnant rats. Nevertheless, our immunohistochemistry data seem to conflict with studies showing that the expression of NPY (and the coexpressed agouti-related peptide) in the ArcN, one major source of PVN NPY inputs, is increased or unchanged during late pregnancy [28] [29] [30] and that PVN NPY Y1R may be elevated. 18 In late pregnant women, CSF concentrations of agouti-related peptide also rise. 31 However, ArcN and PVN NPY regulate multiple modalities, including food intake, which is increased during pregnancy in association with the elevations in the orexigenic peptides, NPY, and agouti-related peptide. 28, 30 Thus, the lack of correlation between whole ArcN NPY expression and the ability of PVN NPY to inhibit SNA during pregnancy may be explained by a differential regulation of ArcN neurons that influence SNA versus those that modulate, for example, energy balance. In support, it has been reported that changes in ArcN NPY/agouti-related peptide and proopiomelanocortin expression during pregnancy vary within the nucleus. 30, 32 Moreover, the altered ArcN regulation of SNA versus energy balance is divergent in another state, obesity. 33 Alternatively, because the PVN also receives a significant NPY projection from the brain stem, 23 it may be that a decrease in this component largely accounts for the decreases in PVN NPY expression and tonic sympathetic inhibition. Future experiments are required to delineate the source of NPY inputs that are diminished during pregnancy. Regardless, collectively, the data support the hypothesis that reduced tonic NPY inhibition of PVN presympathetic neurons supports elevated SNA during pregnancy.
This study also identified 1 source of excitatory support of PVN presympathetic neurons during pregnancy, α-MSH. The ArcN is the primary if not the sole source of PVN α-MSH inputs. 25 However, many studies have reported unchanged or decreased ArcN proopiomelanocortin expression during late pregnancy.
30,34-36 Therefore, in parallel to the results with NPY, it may be that ArcN proopiomelanocortin expression is not relevant to its sympathoexcitatory actions in PVN. Alternatively, because PVN SHU9119 blocks the excitatory effects of PVN NPY1x 17 and withdrawal of tonic NPY inhibition is required to unmask α-MSH excitation, 37 the decrease in tonic NPY inhibition may be sufficient to explain the increased α-MSH drive of PVN presympathetic neurons during pregnancy.
Because pregnancy decreased tonic NPY inhibition and increased α-MSH excitation in PVN and the ArcN is a major source of NPY and α-MSH inputs into PVN, we next tested whether the ArcN, like the PVN, contributes to increased basal SNA. Indeed, inhibition of the ArcN decreased MAP, SSNA, LSNA, and RSNA considerably more in pregnant rats than in nonpregnant rats, suggesting that the excitatory influences from the ArcN, likely mediated in part by α-MSH, predominate. To our knowledge, this is the first demonstration that the ArcN is capable of driving increased basal SNA in any physiological or pathophysiological state. We did not investigate the factors that mediate the changes in ArcN activity during pregnancy, but several candidates immerge. First, insulin and leptin are increased in pregnant women and rats, and both hormones are sympathoexcitatory at least in part by binding to receptors in the ArcN and triggering a pathway that includes the PVN. 20, 21, 38, 39 Second, angiotensin II, via actions at AT1 receptors, supports AP and RSNA during pregnancy, [40] [41] [42] and stimulation of ArcN AT1 receptors increases SNA. 43 Future experiments are required to test these possibilities. Nevertheless, it is noteworthy that although basal raw LSNA and Figure 6 . Effects of acute inhibition of the arcuate nucleus (ArcN) with bilateral nanoinjections of muscimol (musc) on mean arterial pressure (MAP: n=13, NP; n=13, P), heart rate (HR: n=13, NP; n=13, P), lumbar sympathetic nerve activity (LSNA: n=4, NP; n=5, P), splanchnic SNA (SSNA: n=5, NP; n=4, P), and renal SNA (RSNA: n=4, NP; n=4, P) in late pregnant (P) and nonpregnant (NP) rats. The effects of artificial cerebrospinal fluid (aCSF) nanoinjections in NP (LSNA: n=4; SSNA: n=4; RSNA: n=4) and P (LSNA: n=4; SSNA: n=4; RSNA: n=4) rats are also shown. Left and middle, Representative experiments. Grouped data (right) show that ArcN muscimol decreased MAP, LSNA, SSNA, and RSNA more in P than in NP rats and more than aCSF injections. On the other hand, while ArcN muscimol decreased HR in both groups, these responses were not different. Double arrows indicate time of injections. Triangles above the integrated LSNA tracings indicate times at which sections of raw LSNA, shown below, were obtained. *P<0.05 compared to all other groups.
by guest on July 9, 2017 http://hyper.ahajournals.org/ Downloaded from SSNA were more than double in pregnant rats than in nonpregnant rats, complete PVN inhibition or blockade of PVN MC3/4R reduced LSNA by about only 20%, and ArcN muscimol only decreased LSNA, SSNA, and RSNA by slightly >10%. Thus, it would seem that other brain regions are also involved in setting elevated basal SNA tone during pregnancy.
One limitation of this work is that experiments were performed in rats under anesthesia, which can influence autonomic control of the cardiovascular system. However, MAP and HR levels measured in the pregnant and virgin rats used in this study were essentially identical to values obtained using telemetry in conscious rats. 44 In addition, the effect of pregnancy to impair baroreflex control of HR is similar in conscious animals 44, 45 compared with anesthetized 14 animals, as is the pregnancy-induced elevation in basal SNA. Finally, recent studies reveal that the influence of neurotransmitters and neuromodulators, such as GABA and nitric oxide, in the PVN on MAP and HR, is similar in conscious and anesthetized rats. 46 Thus, the effect of anesthesia may be minimal.
Perspectives
Although pregnancy clearly increases basal sympathetic tone, preeclampsia increases it even more. 11 However, the mechanisms are unknown. One hypothesis is that the factors that mediate increased SNA during normal pregnancy contribute to this further elevation. Indeed, preeclampsia is associated with even greater increases in insulin and leptin, and the balance of pressor versus depressor components of the reninangiotensin system is shifted toward the hypertension arm. [47] [48] [49] If true, then before we can identify the cause of sympathetic hyperactivity with hypertensive pregnancy, the mechanisms underlying increased SNA in normal pregnancy must first be established. The present studies, identifying key roles for the PVN and ArcN, is one step toward this goal.
• Blockade of PVN melanocortin type 3/4 receptors decreases LSNA, heart rate, and MAP in pregnant rats but not in nonpregnant rats.
• PVN neuropeptide Y (NPY) expression is reduced in pregnant rats, blockade of PVN NPY Y1 receptors fails to increase LSNA, heart rate, and MAP in pregnant rats, unlike nonpregnant animals, yet the decreases in LSNA, heat rate, and MAP after PVN NPY injections are preserved during pregnancy.
• Inhibition of the arcuate nucleus with muscimol decreases LSNA, splanchnic SNA, renal SNA, and MAP more in pregnant rats than in nonpregnant rats.
What Is Relevant?
• Our partial identification of the neurocircuitry through which normal pregnancy increases SNA may contribute toward an understanding of the mechanisms by which preeclampsia increases SNA even more, because preeclampsia may exaggerate the same processes that elevate SNA during normal pregnancy.
• We show for the first time in any physiological or pathophysiological state that a decrease in tonic PVN NPY inhibition of SNA contributes to basal sympathoexcitation, which may lead to novel pharmacological approaches to treat excess SNA in other conditions, such as hypertension. Figure S1 . Effects of pregnancy on basal levels of mean arterial pressure (MAP), heart rate (HR), lumbar sympathetic nerve activity (LSNA), splanchnic sympathetic nerve activity (SSNA), and renal sympathetic nerve activity (RSNA). Left and middle panels depict representative tracings; the right panel shows grouped data. *: P<0.05, pregnant (P) compared to nonpregnant (NP) rats. 
